Search Results

You are looking at 81 - 90 of 152 items for :

Clear All
Full access

Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Tracy M. Downs, Jason A. Efstathiou, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Noah Hahn, Harry W. Herr, Christopher Hoimes, Brant A. Inman, Masahito Jimbo, A. Karim Kader, Subodh M. Lele, Joshua J. Meeks, Jeff Michalski, Jeffrey S. Montgomery, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Daniel P. Petrylak, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Mark A. Preston, Wade J. Sexton, Arlene O. Siefker-Radtke, Jonathan Tward, Geoffrey Wile, Alyse Johnson-Chilla, Mary A. Dwyer and Lisa A. Gurski

. 10. Meijer RP Mertens LS van Rhijn BW . Induction chemotherapy followed by surgery in node positive bladder cancer . Urology 2014 ; 83 : 134 – 139 . 11. Azuma H Inamoto T Takahara K . The novel bladder preservation therapy BOAI

Full access

Brandon R. Mason, James A. Eastham, Brian J. Davis, Lance A. Mynderse, Thomas J. Pugh, Richard J. Lee and Joseph E. Ippolito

biopsy. The role of multiparametric MRI (mpMRI) has become increasingly important as reflected by NCCN, American Urological Association (AUA), and European Association of Urology (EAU) recommendations ( Table 1 ). 1 – 6 Specifically, the NCCN Clinical

Full access

Robert Torrey, Philippe E. Spiess, Sumanta K. Pal and David Josephson

. 14 Jeong IG Jeong CW Hong SK . Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma . Urology 2006 ; 67 : 709 – 712 . 15 Yoo C Song C Hong JH . Prognostic significance

Full access

Hyung L. Kim, Marvin R. Puymon, Maochun Qin, Khurshid Guru and James L. Mohler

millennium . Urology 2001 ; 58 : 843 – 848 . 6. Kattan MW Eastham JA Stapleton AM . A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer . J Natl Cancer Inst 1998 ; 90 : 766 – 771 . 7

Full access

James L. Mohler

The strategic application of androgen deprivation therapy (ADT) in the clinic is still evolving, according to James L. Mohler, MD, Chair of the Department of Urology and Associate Director of Translational Research, Roswell Park Cancer Institute

Full access

Michelle E. Melisko and Joseph B. Narus

Wagner G . The international index of erectile function: a multidimensional scale for assessment of erectile dysfunction . Urology 1997 ; 49 : 822 – 830 . 7. Mazzarello S Hutton B Ibrahim MF . Management of urogenital atrophy in breast

Full access

Matt Brow, J. Russell Hoverman, Debra Patt, Bill Herman, Diana Verrilli, Jody Garey and Roy Beveridge

concepts are at the core of cancer care delivery, whether in the community or academic setting and across specialties, including medical oncology, radiation oncology, gynecologic oncology, urology, and surgery. Achieving quality will require integrated

Full access

Peter R. Carroll and Andrew J. Vickers

, MD, MPH, Professor and Chair, Department of Urology, University of California, San Francisco, the answer depends on screening younger men than in the past, adherence to strict criteria for biopsy, aggressive treatment of men with high-risk disease

Full access

Celestia S. Higano

Understanding clinical disease states in castration-resistant prostate cancer (CRPC) is important to making intelligent choices for therapy for patients, said Celestia S. Higano, MD, Professor, Departments of Medicine and Urology, University of

Full access

Andrew J. Armstrong

Chodak G Whitmore JB . Lower baseline prostate-specific antigen is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial . Urology 2013 ; 81 : 1297 – 1302